Stanford is looking for 200 volunteers with long COVID to test Paxlovid, in the nation’s first such study
Stanford Medicine is seeking volunteers for the nation’s first clinical trial to determine if the antiviral drug Paxlovid can combat one of the thorniest issues of COVID-19 affecting millions of people: the known long-term debilitating symptom suite. under the name of long COVID. There is currently no treatment and many people turn to risky and …